Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan for Early Diabetic Glomerulopathy in Type 1 Diabetes
NCT00328302Phase 4Unknown
- Sponsor
- Karolinska University Hospital
- Start
- Sep 2000
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of candesartan in diabetic glomerulopathy (DKD), sponsored by Karolinska University Hospital. Status: unknown.
02
Drugs
candesartan
03
Conditions
diabetic glomerulopathy (DKD)
Beyond the preview
Go deeper on NCT00328302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00328302.